SK Hynix vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? SK Hynix trades at $169.67 (market cap $891.31B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B). The key difference: SK Hynix is far larger — about 392.6× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SK Hynix pays a 0.06% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| SKHY | SLS | |
|---|---|---|
Market Cap | $891.31B | $2.27B |
Volume | 22,268,296 | 4,179,659 |
Sector | Technology | Health |
52-Week High | $198.63 | $15.46 |
52-Week Low | $126.79 | $1.39 |
Typical Hold Time | 10 Days | — |
Enterprise Value | $841.45B | $2.14B |
Dividend Yield | 0.06% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
SK hynix is a South Korean semiconductor company that manufactures memory products, including DRAM and NAND flash. Its high-bandwidth memory (HBM) products are designed for high-performance computing and AI applications.
Read more on SKHY →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →